PHARMACOKINETIC/PHARMACODYNAMIC ANALYSIS OF HUMAN ANTI-C1S ANTIBODY (TNT009) AND CLASSICAL COMPLEMENT PATHWAY (CP) ACTIVITY

被引：0
|
作者：
Jilma, B. [1 ]
Gilbert, J. [2 ]
Nix, D. [2 ]
Chang, C. [3 ]
Beliveau, M. [3 ]
Marier, J. [3 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] True North Therapeut Inc, San Francisco, CA USA
[3] Certara Strateg Consulting, Montreal, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-018
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 33 条
  • [21] TNT009, a monoclonal antibody inhibitor of C1s, induces a rapid and complete remission of anemia in primary cold agglutinin disease patients
    Panicker, Sandip
    Parry, Graham C.
    Fillitz, Michael
    Schenk, Thomas
    Sillaber, Christian
    Bartko, Johann
    Gilbert, James C.
    Jaeger, Ulrich
    Jilma, Bernd
    IMMUNOBIOLOGY, 2016, 221 (10) : 1170 - 1171
  • [22] Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD)
    Jilma, Bernd
    Gilbert, James C.
    Panicker, Sandip
    Parry, Graham C.
    Fillitz, Michael
    Thomas, Schenk
    Sillaber, Christian
    Bartko, Johann
    Jaeger, Ulrich
    BLOOD, 2016, 128 (22)
  • [23] Classical Pathway of Complement Activation in ITP: Inhibition By TNT003, a Novel C1s Inhibitor
    Peerschke, Ellinor I. B.
    Panicker, Sandip
    Sughroue, Alexa M.
    Bussel, James B.
    BLOOD, 2014, 124 (21)
  • [24] Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejectionresults from a first-in-patient phase 1 trial
    Eskandary, F.
    Jilma, B.
    Muehlbacher, J.
    Wahrmann, M.
    Regele, H.
    Kozakowski, N.
    Firbas, C.
    Panicker, S.
    Parry, G. C.
    Gilbert, J. C.
    Halloran, P. F.
    Boehmig, G. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (04) : 916 - 926
  • [25] Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients
    Jaeger, Ulrich
    D'Sa, Shirley
    Schoergenhofer, Christian
    Bartko, Johann
    Sillaber, Christian
    Jilma-Stohlawetz, Petra
    Fillitz, Michael
    Schenk, Thomas
    Patou, Gary
    Panicker, Sandip
    Parry, Graham C.
    Gilbert, James C.
    Jilma, Bernd
    BLOOD, 2017, 130
  • [26] TNT003, A MONOCLONAL ANTIBODY AGAINST THE COMPLEMENT COMPONENT C1S, INHIBITED IN VITRO EFFICIENT ALLOANTIBODY-INDUCED CLASSICAL COMPLEMENT ACTIVATION
    Muehlbacher, J.
    Marinova, L.
    Huttary, N.
    Regele, H.
    Eskandary, F.
    Gilbert, J.
    Panicker, S.
    Boehmig, G. A.
    Wahrmann, M.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 12 - 12
  • [27] RAY121, a Novel Recycling Monoclonal Antibody Against Complement C1s: Safety, Pharmacokinetic and Pharmacodynamic Data from a Phase 1a First in Human Clinical Trial in Healthy Adults
    Haranaka, Miwa
    Yamada, Akinori
    Takahashi, Saki
    Gotanda, Keisuke
    Nakano-Kanatani, Sonoko
    Uemura, Nana
    Ohnishi, Kensuke
    Nishidate, Masanobu
    Ohnami, Ichio
    Kai, Megumi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 580 - 582
  • [28] Association of C4d with disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis: evidence for classical/lectin complement pathway activation
    Juto, Anna
    Martin, Myriam
    Bjork, Albin
    Padyukov, Leonid
    Gronwall, Caroline
    Antovic, Aleksandra
    Bruchfeld, Annette
    Gunnarsson, Iva
    Blom, Anna M.
    ARTHRITIS RESEARCH & THERAPY, 2025, 27 (01)
  • [29] Results of Single-Arm, Phase 1b Study of Anti-C1q Treatment (ANX009) Show That the Classical Pathway Is a Key Driver of Complement Activation and Consumption in Patients with Active Lupus Nephritis
    Dall'Era, Maria
    Lichauco, Juan
    Chen, Hsiang
    Gomez, Harold
    Tee, Michael
    Arroyo, Caroline
    Lan, Joung-Liang
    Fang, Yao-Fan
    Chang, Edmund
    Yousefpour, Noosha
    Low, Julian
    Bao, Min
    Chang, Qing
    Osterloh, Jeannette
    Mongan, Ann
    Yednock, Ted
    Artis, Dean
    Andrews-Zwilling, Yaisa
    Kroon, Henk-Andre
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4632 - 4633
  • [30] ACTIVATION OF THE HUMAN CLASSICAL COMPLEMENT PATHWAY BY A MOUSE MONOCLONAL HYBRID IGG1-2A MONO-VALENT ANTI-TNP ANTIBODY BOUND TO TNP-CONJUGATED CELLS
    COUDERC, J
    KAZATCHKINE, MD
    VENTURA, M
    DUC, HT
    MAILLET, F
    THOBIE, N
    LIACOPOULOS, P
    JOURNAL OF IMMUNOLOGY, 1985, 134 (01): : 486 - 491
1234